Page 380 - SAHCS HIVMed Journal Vol 20 No 1 2019

Page 7 of 8 Original Research

42. Abrams EJ, Ananworanich J, Archary M, Ngongondo M, Brouwers P. Propelling the 46. Kuhn L, Shiau S. The pharmacological treatment of acute HIV infections in
pediatric HIV therapeutic agenda with science, innovation, and collaboration. J neonates. Expert Rev Clin Pharmacol. 2017;10(12):1353–1361. https://doi.org/
Acquir Immune Defic Syndr. 2018;78(Suppl 1):S32–S39. https://doi.org/10.1097/ 10.1080/17512433.2017.1398645
QAI.0000000000001747 47. Goga AE, Singh Y, Singh M, et al. Enhancing HIV treatment access and outcomes
43. Shiau S, Kuhn L. Antiretroviral treatment in HIV-infected infants and young amongst HIV infected children and adolescents in resource limited settings. Matern
children: Novel issues raised by the Mississippi baby. Expert Rev Anti Infect Ther. Child Health J. 2017;21(1):1–8. https://doi.org/10.1007/s10995-016-2074-1
2014;12(3):307–318. https://doi.org/10.1586/14787210.2014.888311 48. Ford ND, Stein AD. Risk factors affecting child cognitive development: A summary
44. Taha TE, Nour S, Kumwenda NI, et al. Gender differences in perinatal HIV of nutrition, environment, and maternal-child interaction indicators for sub-
Saharan Africa. J Dev Orig Health Dis. 2016;7(2):197–217. https://doi.org/
acquisition among African infants. Pediatrics. 2005;115(2):e167–e172. https:// 10.1017/S2040174415001427
doi.org/10.1542/peds.2004-1590
45. Davies MA. Research gaps in neonatal HIV-related care. South Afr J HIV Med. 49. Walker SP, Wachs TD, Grantham-McGregor S, et al. Inequality in early childhood:
Risk and protective factors for early child development. Lancet. 2011;378(9799):
2015;16(1):375. https://doi.org/10.4102/sajhivmed.v16i1.375 1325–1338. https://doi.org/10.1016/S0140-6736(11)60555-2

Appendix starts on the next page →

http://www.sajhivmed.org.za 373 Open Access